SCLP — Scancell Holdings Share News
0.000.00%
- £101.18m
- £100.56m
- £4.71m
REG - Scancell Hlds - Retail Offer for up to £1 million
AnnouncementREG - Scancell Hlds - Proposed fundraise in excess of £8.5 million
AnnouncementREG - Scancell Hlds - Second Commercial License Agreement with Genmab
AnnouncementREG - Scancell Hlds - Positive data from Phase 2 SCOPE trial with SCIB1
AnnouncementREG - Scancell Hlds - Result of Annual General Meeting
AnnouncementREG - Scancell Hlds - Holding(s) in Company
AnnouncementREG - Scancell Hlds - Scancell Appoints Dr Phil L’Huillier as CEO
AnnouncementREG - Scancell Hlds - Notice of AGM
AnnouncementREG - Scancell Hlds - Results Year Ended 30 April 2024
AnnouncementREG - Scancell Hlds - Notice of Final Results
AnnouncementREG - Scancell Hlds - Strategic Partnership with PharmaJet
AnnouncementREG - Scancell Hlds - Scancell to attend upcoming conferences
AnnouncementREG - Scancell Hlds - Scancell Appoints Dr Nermeen Varawalla as CMO
AnnouncementREG - Scancell Hlds - Update from iSCIB1+ Clinical Advisory Meeting
AnnouncementREG - Scancell Hlds - Appointment of Dr Florian Reinaud to the Board
AnnouncementREG - Scancell Hlds - Extension of Convertible Loan Notes
AnnouncementREG - Scancell Hlds - Block Listing Return and Total Voting Rights
AnnouncementREG - Scancell Hlds - Change of Nominated Advisor
AnnouncementREG - Scancell Hlds - Agreement with major biotech
Announcement